Education
About Us
Working with TipRanks
Follow Us
IQVIA Holdings Inc (IQV)
NYSE:IQV
Noc-110
Refractory Or Unexplained Chronic Cough
Phase II
Recruiting
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough
Jul 11, 2024
―
Atozet 10/40 Mg Or 10/80 Mg, Lipitor 40 Mg Or 80 Mg
Atherosclerotic Cardiovascular Disease
Phase IV
Completed
Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients
Feb 27, 2023
―
Avt05, Simponi
Healthy Adult Subjects
Phase I
Completed
A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants
Nov 11, 2022
―
Og-6219
Endometriosis
Phase II
Completed
A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain
Sep 20, 2022
―
Paclitaxel, Carboplatin, Oregovomab
Ovarian Cancer, Ovarian Neoplasms, Peritoneal Carcinoma, Peritoneal Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Serous Adenocarcinoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma
Phase III
Active Not Recruiting
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
Jul 28, 2020
―
Pembrolizumab (Keytruda®), Ctx-471
Melanoma, Non-small Cell Lung Cancer, Small Cell Lung Cancer, Metastatic Cancer, Head And Neck Cancer, Mesothelioma, Locally Advanced Solid Tumor
Phase I
Completed
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Mar 13, 2019
―
Imr-687
Sickle Cell Disease, Sickle-Cell; Hb-Sc, Sickle Beta 0 Thalassemia
Phase I
Completed
A Study of IMR-687 in Healthy Adult Volunteers
Dec 06, 2016
―
3 G Or 6 G Zidebactam
Healthy Subjects
Phase I
Completed
MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults
Jan 25, 2016
―
Leo 90105 = Calcipotriol + Betamethasone Dipropionate, Dovonex® = Calcipotriol, Rinderon® - Dp = Betamethasone Dipropionate
Psoriasis
Phase III
Completed
LEO 90105 Ointment in Japanese Subjects With Psoriasis
Aug 15, 2011
―
Leo 90105
Healthy
Phase I
Completed
A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects
Feb 09, 2011
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does IQVIA Holdings Inc (IQV) have in its pipeline
IQV is currently developing the following drugs: Noc-110, Atozet 10/40 Mg Or 10/80 Mg, Lipitor 40 Mg Or 80 Mg, Avt05, Simponi. These drug candidates are in various stages of clinical development as the company works toward FDA approval.